Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05202119 · ClinicalTrials.gov registry record · NA
Empower: tDCS for Major Depressive Disorder at Home
A NA study of Major Depressive Disorder, sponsored by Flow Neuroscience AB.
- Completed
- Registry status
- NA
- Development phase
- 174
- Enrollment target
- 2
- Study locations
NCT05202119 is a NA study of Major Depressive Disorder that has completed, run by Flow Neuroscience AB. The registered enrollment target is 174 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (54% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05202119, a NA study of Major Depressive Disorder, has completed, sponsored by Flow Neuroscience AB.
- COMPLETED
- Registry status
- NA
- Development phase
- 174 participants
- Enrollment target
- 2
- Study locations
Study Summary
A two-center trial to investigate whether or not active stimulation with the Flow FL-100 tDCS device is superior to sham stimulation for the treatment of major depressive disorder when used at home. Participants perform up to 36 tDCS sessions by themselves without supervision during a blinded 10-week phase, and then 30 more sessions during an unblinded open-label phase.
Conditions Studied
Interventions
- DEVICE Transcranial direct current stimulation
- DEVICE Sham Transcranial direct current stimulation
Study Locations (2)
Texas
- UT Health Science Center - Houston
Other
- School of Psychology, University East London - London
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2023-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05202119
The ClinicalTrials.gov registry entry for NCT05202119 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (54% lower). The listed sponsor is Flow Neuroscience AB, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Transcranial direct current stimulation is the first listed.
NCT05202119 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Texas, Other.
Frequently Asked Questions
What is clinical trial NCT05202119 about?
NCT05202119 is a clinical study titled "Empower: tDCS for Major Depressive Disorder at Home". A two-center trial to investigate whether or not active stimulation with the Flow FL-100 tDCS device is superior to sham stimulation for the treatment of major depressive disorder when used at home. Participants perform up to 36 tDCS sessions by themselves without supervision during a blinded 10-we...
What is the current status of trial NCT05202119?
This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2022-05-01. Estimated completion is 2023-08-31.
What conditions does trial NCT05202119 study?
This clinical trial studies the following conditions: Major Depressive Disorder.
What interventions are being tested in trial NCT05202119?
The interventions under investigation include: Transcranial direct current stimulation (DEVICE), Sham Transcranial direct current stimulation (DEVICE).
Who is sponsoring clinical trial NCT05202119?
This trial is sponsored by Flow Neuroscience AB, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05202119 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
-
Positive Processes and Transition to Health (PATH)
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.